Cancer and the Long-Term Costs of ICER’s Short-Term Thinking
![](https://allianceforpatientaccess.org/wp-content/uploads/2023/11/AdobeStock_250320820-scaled-1-1024x683.jpeg)
The heartbreaking headline said it all: a new CAR-T personalized cancer treatment was found “effective, but too costly” by the economists at the Institute for Clinical and Economic Research.